https://doi.org/10.4081/reumatismo.2018.1028

Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study

Vol. 70 No. 2 (2018)
Submitted: 5 June 2017
Accepted: 17 December 2017
Published: 6 July 2018
Rheumatoid arthritis.
Abstract Views: 2275
PDF: 781
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

A. Alunno
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
O. Bistoni
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
F. Pratesi
Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
F. Topini
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
I. Puxeddu
Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
V. Valentini
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
G. Cafaro
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
E. Bartoloni
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
P. Migliorini
Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
R. Gerli
roberto.gerli@unipg.it
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
In recent years several antibodies against citrullinated peptides (ACPAs) have been identified in patients with rheumatoid arthritis (RA) and their pathogenic, diagnostic and prognostic significance is under intense investigation. Among ACPAs, those targeting citrullinated alpha enolase (anti-CEP1) have been identified in RA but data about their ability to predict the development of erosive disease are conflicting. Furthermore, no data are currently available concerning their possible association with extra-articular manifestations (EAMs) in RA. The aim of this study was to investigate the prevalence and significance of anti-CEP1 from a prognostic point of view. In this pilot study we confirmed that anti-CEP1 Abs are associated with higher prevalence of bone erosions, but we also provided the first evidence of an association between anti-CEP1 Abs and RA interstitial lung disease (ILD). These results provide the basis to investigate the association between anti-CEP1 Abs and EAMs in larger cohorts of RA patients to possibly confirm its role as biomarker for RA-ILD.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Alunno, A., Bistoni, O., Pratesi, F., Topini, F., Puxeddu, I., Valentini, V., … Gerli, R. (2018). Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study. Reumatismo, 70(2), 67–71. https://doi.org/10.4081/reumatismo.2018.1028

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.